Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell-surface heparan sulfate (HS) is a complex linear polysaccharide belonging to the glycosaminoglycan family, typically found covalently attached to core proteins to form heparan sulfate proteoglycans (HSPGs) such as syndecans and glypicans (Bishop et al., 2007, Nature Reviews Molecular Cell Biology). These molecules are ubiquitous on the surface of almost all animal cells and within the extracellular matrix, where they serve as critical co-receptors for a wide array of ligands, including growth factors, chemokines, and morphogens (Knelson et al., 2014, Nature Reviews Cancer). By sequestering and presenting signaling molecules like fibroblast growth factors (FGFs) and vascular endothelial growth factors (VEGFs) to their high-affinity receptors, HS plays a fundamental role in regulating developmental signaling, cell proliferation, and tissue homeostasis (Vlodavsky et al., 2012, Matrix Biology). In pathological contexts, HS is frequently exploited by various pathogens, including SARS-CoV-2 and herpes simplex virus, as an initial attachment point for cellular entry (Cagno et al., 2019, Antiviral Chemistry & Chemotherapy). Furthermore, the enzymatic remodeling of HS by heparanase is a key driver of cancer progression, promoting tumor angiogenesis, inflammation, and metastasis (Hammond et al., 2014, Journal of Medicinal Chemistry). Therapeutic strategies targeting HS include the development of HS mimetics that competitively inhibit ligand binding or small molecules that block heparanase activity to disrupt the pro-tumorigenic and pro-viral microenvironment.
Competitive inhibition of ligand binding to cell-surface HS chains and inhibition of heparanase-mediated degradation of the glycocalyx to prevent signaling and metastasis.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell-surface heparan sulfate (HS) (HS).